Edwards Lifesciences shares are trading higher after Wolfe Research upgraded the stock from Underperform to Peer Perform.
Portfolio Pulse from Benzinga Newsdesk
Edwards Lifesciences shares are trading higher after Wolfe Research upgraded the stock from Underperform to Peer Perform.
July 29, 2024 | 10:58 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Edwards Lifesciences shares are trading higher following an upgrade by Wolfe Research from Underperform to Peer Perform.
The upgrade from Wolfe Research is a positive signal for investors, likely leading to increased buying interest and a short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100